Bioprocess Bags Market Trends

Growth Drivers

• Increasing number of contract development and manufacturing organizations (CDMOs): CDMOs play a crucial role in the biopharmaceutical sector as these help to scale up production quickly without the need for robust in-house infrastructure. These rely heavily on single-use technologies like bioprocess bags to ensure faster turnaround times and lower costs. As CDMOs handle multiple clients, single use bags can prevent cross-contamination between batches. Many small to medium-scale companies with limited manufacturing capabilities often prefer CDMOs as these provide cost-effective access to advanced bioprocessing facilities. Thus, the rising number of CDMOs across the globe is expected to fuel market growth going ahead.

• Rapid advancements in bioprocessing technology: Continuous innovation in the biomanufacturing processes, such as automation and digitalization, has resulted in better production methods. These advancements allow better scalability, reduced operational costs, and enhanced product yield, increasing the need for advanced bioprocess bags. For instance, in April 2023, Merch announced the launch of Ultimus, a single-use process container film to offer superior strength along with leak resistance for single use assemblies for bioprocessing liquid applications.

Challenges

• Surging cost of raw material: Bioprocess bags require high-quality, specialized materials that are often expensive than conventional plastics. Moreover, the sterilization process ensures their suitability for biopharmaceutical applications, which adds to the production costs.

• Rising environmental issues with the adoption of single use bioprocess bags: The rising use of single use bioprocess bags made from non-biodegradable plastics can contribute to plastic waste and greenhouse gas emissions. This can affect the overall market growth going ahead.